Format

Send to

Choose Destination
Am J Trop Med Hyg. 2018 Nov;99(5):1114-1116. doi: 10.4269/ajtmh.18-0591.

To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma.

Author information

1
Centre for the AIDS Programme of Research in South Africa (CAPRISA)-Medical Research Council TB-HIV Pathogenesis and Treatment Unit, Durban, South Africa.
2
Department of Epidemiology and Biostatistics, McGill International TB Centre, McGill University, Montreal, Canada.
3
International Institute for Social Studies, Erasmus University, Rotterdam, Netherlands.
4
Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, California.
5
Volunteer Heath Services, Addis Ababa, Ethiopia.
6
United Nations Special Envoy for Tuberculosis, San Francisco, California.

Abstract

World leaders gather to consolidate their commitment to ending tuberculosis (TB). Vital to the success of renewed efforts is an overdue recognition of the pervasive and pernicious influence of TB stigma. TB stigma is sustained in structures, policies, traditions, and norms. Innovative modifications to infection control, drug dispensing, and surveillance practices are required to increase demand for TB screening and effective therapeutic alliances among those diagnosed. The authors argue that reducing TB stigma requires a scientific and inclusive process, with prominent roles for TB survivors and a willingness to integrate and learn from other stigmatized conditions.

PMID:
30226149
PMCID:
PMC6221214
[Available on 2019-11-01]
DOI:
10.4269/ajtmh.18-0591

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center